Vireo Growth Inc. has made significant strides in its merger with Planet 13 Holdings, as detailed in a recent SEC filing. The company announced an amendment to its merger agreement, responding to regulatory requests from the Illinois Department of Financial and Professional Regulation (IDFPR). This amendment is crucial as it addresses compliance concerns regarding cannabis licensing in Illinois, which could affect the operational landscape for both Vireo and its competitors in the pharmaceutical preparations sector.
Vireo Growth Inc. operates in the pharmaceutical preparations industry, focusing on cannabis-related products. The company, trading under the ticker symbol VREOF on the OTC exchange, is based in Minneapolis, Minnesota. It has undergone several name changes, previously known as Goodness Growth Holdings, Inc. and Vireo Health International, Inc. The latest filing, dated November 17, 2026, highlights the ongoing evolution of the company as it seeks to expand its market presence through strategic mergers.
The SEC filing reveals that Vireo and Planet 13 entered into a merger agreement on July 26, 2026. This agreement includes a provision for Planet 13 to merge with Vireo’s wholly-owned subsidiary, Supernova Merger Sub Inc. The recent amendment made on November 12, 2026, clarifies specific provisions related to Planet 13’s Illinois cannabis license. Notably, it ensures that the merger does not contravene applicable Illinois law regarding the assignment of cannabis licenses.
Vireo’s decision to amend the merger agreement is a proactive measure to align with regulatory expectations, which is vital in the cannabis industry where compliance is paramount. The amendment specifically addresses the regulatory approval closing condition, emphasizing the need for IDFPR approval for the change in ownership and control of Planet 13’s Illinois adult-use dispensing license. This clarity is expected to facilitate smoother regulatory navigation as the merger progresses.
The implications of this amendment extend beyond Vireo and Planet 13. Other companies in the pharmaceutical preparations sector, particularly those involved in cannabis, are likely to take note of the regulatory challenges and compliance requirements highlighted by this merger. As the cannabis industry continues to evolve, maintaining regulatory compliance will be a critical factor for success.
Looking ahead, the merger is set to be voted on by Planet 13’s stockholders during a special meeting scheduled for December 10, 2026. The outcome of this vote will be pivotal for both companies as they work to finalize the merger and integrate their operations. The filing indicates that further relevant materials may be filed with the SEC and Canadian securities regulators regarding the merger, keeping stakeholders informed throughout the process.
In conclusion, Vireo Growth’s amendment to its merger agreement with Planet 13 Holdings marks a significant step in addressing regulatory concerns that could impact the cannabis market. As the company navigates this complex landscape, its actions may serve as a precedent for others in the pharmaceutical preparations sector, highlighting the importance of regulatory compliance in achieving successful mergers and acquisitions.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





